ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 07/01/2022
Closing price: 210.63
Support price level: $195.84
Resistance price level: $214.09
Relative strength index (14-day RSI) 60.9
Beta 0.89
  • With a -39.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • BIIB is one of this month's top performers with a return of 6.1 percent, beating 90 percent of stocks in the S&P-100.

  • Volatility is forecast to rise over the next month.

Low High Price as % of Range
$187.54 $369.05 17.2%
200 day 50 day 20 day 10 day
$230.16 $202.36 $202.76 $207.48
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
44.3% 39.4% 40.6% 46.9%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 11.0% in the next week.

  • 26.5% in the next month.

  • 105.6% in the next year.